Biphenotypic hematologic malignancy a case report of the 8p11 myeloproliferative syndrome in a child

Journal of Pediatric Hematology/Oncology

Volumn 32, Issue 6, 2010, Pages 501-503

  Chen, Xiangli ^a   Zhang, Yin ^a   Li, Yulong ^a   Lei, Pingchong ^a   Zhai, Yaping ^a   Liu, Linxiang ^b  

^a HENAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

^b ZHENGZHOU UNIVERSITY   (China)

Author keywords

8p11 myeloproliferative syndrome; CML; FGFR1; T LBL

Indexed keywords

CD14 ANTIGEN; CD19 ANTIGEN; CD2 ANTIGEN; CD20 ANTIGEN; CD3 ANTIGEN; CD33 ANTIGEN; CD34 ANTIGEN; CD56 ANTIGEN; CD64 ANTIGEN; CD7 ANTIGEN; CD99 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DNA NUCLEOTIDYLEXOTRANSFERASE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; HYDROXYUREA; LEUKOCYTE ANTIGEN; LEUKOSIALIN; MICROSOMAL AMINOPEPTIDASE; PREDNISONE; STEM CELL FACTOR RECEPTOR; VINCRISTINE; ANTINEOPLASTIC AGENT; CVAD PROTOCOL; EPOCH PROTOCOL;

8P11 MYELOPROLIFERATIVE SYNDROME; ACUTE BIPHENOTYPIC LEUKEMIA; ALLOGENEIC STEM CELL TRANSPLANTATION; ANTIGEN EXPRESSION; ARTICLE; AXILLARY LYMPH NODE; BLAST CELL; BLOOD CELL COUNT; BONE MARROW BIOPSY; BONE MARROW EXAMINATION; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CASE REPORT; CERVICAL LYMPH NODE; CHILD; CHROMOSOME ANALYSIS; CHROMOSOME BAND; CHRONIC MYELOMONOCYTIC LEUKEMIA; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; ECHOGRAPHY; EOSINOPHILIA; ERYTHROBLAST; FLOW CYTOMETRY; GRANULOCYTE; GRANULOPOIESIS; HEPATOSPLENOMEGALY; HUMAN; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; INGUINAL LYMPH NODE; KARYOTYPE; LEUKOCYTE COUNT; LUNG NODULE; LYMPHADENOPATHY; LYMPHOBLASTOMA; MALE; MALIGNANT TRANSFORMATION; MEDIASTINUM; MEGAKARYOCYTE; MONOCYTOSIS; MULTIPLE CYCLE TREATMENT; MYELOBLAST; MYELOPROLIFERATIVE DISORDER; PRE B LYMPHOCYTE; PRIORITY JOURNAL; PROMYELOCYTE; SCHOOL CHILD; SPLEEN; T LYMPHOCYTE; ACUTE LYMPHOBLASTIC LEUKEMIA; CHROMOSOME 13; CHROMOSOME 8; GENE TRANSLOCATION; GENETICS; PATHOPHYSIOLOGY; PHENOTYPE; PRECANCER; SYNDROME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHROMOSOMES, HUMAN, PAIR 13; CHROMOSOMES, HUMAN, PAIR 8; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; HUMANS; MALE; MYELOPROLIFERATIVE DISORDERS; PHENOTYPE; PRECANCEROUS CONDITIONS; PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PREDNISONE; SYNDROME; TRANSLOCATION, GENETIC; VINCRISTINE;

EID: 77955899481     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e3181e413fa     Document Type: Article

References (20)

1. Kantarjian HM, O'Brien S, Smith TL, et al. Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia. J Clin Oncol. 2000;18: 547-561.
2. Xiao S, Nalabolu SR, Aster JC, et al. FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaemia/ lymphoma syndrome. Nat Genet. 1998;18:84-87.
3. Abruzzo LV, Jaffe ES, Cotelingam JD, et al. T-cell lymphoblastic lymphoma with eosinophilia associated with subsequent myeloid malignancy. Am J Surg Pathol. 1992;16:236-245.
4. Inhorn RC, Aster JC, Roach SA, et al. A syndrome of lymphoblastic lymphoma, eosinophilia, and myeloid hyperplasia/malignancy associated with t(8;13)(p11;q11): description of a distinctive clinicopathologic entity. Blood. 1995;85:1881-1887.
5. Macdonald D, Aguiar RC, Mason PJ, et al. A new myeloproliferative disorder associated with chromosomal translocations involving 8p11: a review. Leukemia. 1995;9: 1628-1630.
6. Wong WS, Cheng KC, Lau KM, et al. Clonal evolution of 8p11 stem cell syndrome in a 14-year-old Chinese boy: a review of literature of t(8;13) associated myeloproliferative diseases. LeukRes. 2007;31:235-238.
7. Macdonald D, Reiter A, Cross NC. The 8p11 myeloproliferative syndrome: a distinct clinical entity caused by constitutive activation of FGFR Acta Haematol. 2002;107:101-107.
8. Zhang WW, Habeebu S, Sheehan AM, et al. Molecular monitoring of 8p11 myeloproliferative syndrome in an infant. J Pediatr Hematol Oncol. 2009;31:879-883.
9. Friedhoff F, Rajendra B, Moody R, et al. Novel reciprocal translocation between chromosomes 8 and 9 found in a patient with myeloproliferative disorder. Cancer Genet Cytogenet. 1983;9:391-394.
10. Roy S, Szer J, Campbell LJ, et al. Sequential transformation of t(8;13)-related disease: a case report. Acta Haematol. 2002; 107:95-97.
11. Still IH, Chernova O, Hurd D, et al. Molecular characterization of the t(8;13)(p11;q12) translocation associated with an atypical myeloproliferative disorder: evidence for three discrete loci involved in myeloid leukemias on 8p Blood. 1997;90: 3136-3141.
12. Popovici C, Zhang B, Gregoire MJ, et al. The t(6;8)(q27;p11) translocation in a stem cell myeloproliferative disorder fuses a novel gene, FOP, to fibroblast growth factor receptor Blood. 1999;93:1381-1389.
13. Martinez-Climent JA, Vizcarra E, Benet I, et al. Cytogenetic response induced by interferon alpha in the myeloproliferative disorder with eosinophilia, T cell lymphoma and the chromosomal translocation t(8;13)(p11;q12). Leukemia. 1998;12: 999-1000.
14. Walz C, Chase A, Schoch C, et al. The t(8;17)(p11;q23) in the 8p11 myeloproliferative syndrome fuses MYO18A to FGFR Leukemia. 2005;19:1005-1009.
15. Agerstam H, Lilljebjorn H, Lassen C, et al. Fusion gene-mediated truncation of RUNX1 as a potential mechanism underlying disease progression in the 8p11 myeloproliferative syndrome. Genes Chromosomes Cancer. 2007;46:635-643.
16. Yamamoto K, Kawano H, Nishikawa S, et al. A biphenotypic transformation of 8p11 myeloproliferative syndrome with CEP1/FGFR1 fusion gene. Eur J Haematol. 2006;77:349-354.
17. Etienne A, Gelsi-Boyer V, Carbuccia N, et al. Combined translocation with ZNF198-FGFR1 gene fusion and deletion of potential tumor suppressors in a myeloproliferative disorder. Cancer Genet Cytogenet. 2007;173:154-158.
18. Xiao S, McCarthy JG, Aster JC, et al. ZNF198-FGFR1 transforming activity depends on a novel proline-rich ZNF198 oligomerization domain. Blood. 2000;96:699-704.
19. Goradia A, Bayerl M, Cornfield D. The 8p11 myeloproliferative syndrome: review of literature and an illustrative case report. Int J Clin Exp Pathol. 2008;1:448-456.
20. Demiroglu A, Steer EJ, Heath C, et al. The t(8;22) in chronic myeloid leukemia fuses BCR to FGFR1: transforming activity and specific inhibition of FGFR1 fusion proteins. Blood. 2001;98:3778-3783.